According to media reports, Paul Stoffels, Galapagos' previous CEO, has assembled a group of investors to bid for the company's cell therapy business. After joining Galapagos in 2022, Paul Stoffels pivoted the company towards cell therapies and focussed the company's efforts on de-centralised CAR-T manufacturing as a way to broaden access to such treatments. Following his resignation earlier this year, he now has placed a non-binding offer for the cell therapy business which is under strategic r...
It was not only the announcement itself but the speed at which Fugro had to come back on its original guidance. In the past 7-8 weeks, Fugro has been hit with two major negative events: the oil and gas market has turned sour on top of the struggling offshore wind market. Now, three-quarters of Fugro's revenues is facing challenges, we believe not only FY25 will suffer but now also the outlook for FY26 has weakened. This results in a materially lower EBITDA forecast than we previously had incorpo...
DEME secures sizable contract for Nordseecluster B wind farm in Germany DEME has secured a sizable contract to carry out the transport and installation works for the inter-array cables for the Nordseecluster B offshore wind farm in Germany. The Nordseecluster is a joint offshore wind project of RWE (51%) and Norges Bank Investment Management (49%). Attachment
DEME wint omvangrijk contract voor het Nordseecluster B windpark in Duitsland DEME heeft een omvangrijk contract binnengehaald voor het transport en de installatie van de inter-array kabels voor het offshore windpark Nordseecluster B in Duitsland. De Nordseecluster is een gezamenlijk offshore windproject van RWE (51%) en Norges Bank Investment Management (49%). Bijlage
Galapagos announced that it has received a limited number of non-binding offers from consortia, predominantly comprised of financial investors, to acquire the cell therapy business. The deadline for potential bidders to put forward binding, fully-financed, offers is in the coming weeks. The company will make an announcement on the outcome of the review of strategic alternatives for the cell therapy business no later than its 3Q25 update on 5 November 2025. € 37 TP and ACCUMULATE reiterated.
In this October update of our Dynamic Top Pick List we are removing VGP while adding Shurgard and Wolters Kluwer. Since its recent inclusion in our Dynamic Top Pick List in July-25, VGPs share rose by 10.6%. While we still believe there is significant upside to the share price, we don't see short term catalysts. In fact, the macro picture remains cloudy with the jury still out on the impact of tariffs and the erratic US policy shifts. Also, we are a bit concerned that competition in Western Eur...
Galapagos Provides Update on Strategic Alternatives for Its Cell Therapy Business Mechelen, Belgium; October 1, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) and its Board of Directors today issued the following statement: On May 13, 2025, Galapagos announced that its Board of Directors (the “Board”) had decided to explore all strategic alternatives for its cell therapy business (the “Cell Therapy Business”), including a potential divestiture of the Cell Therapy Business, with the goal of preserving shareholder value. As part of its review of strategic alternatives, over ...
Galapagos geeft update over strategische alternatieven voor haar celtherapieactiviteiten Mechelen, België; 1 oktober 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) en haar Raad van Bestuur hebben vandaag de volgende verklaring uitgegeven: Op 13 mei 2025 kondigde Galapagos aan dat haar Raad van Bestuur (de “Raad”) had besloten om alle strategische alternatieven voor haar celtherapieactiviteiten (de “Celtherapieactiviteiten”) te verkennen, met inbegrip van een mogelijke verkoop van de Celtherapieactiviteiten, met als doel het waarborgen van aandeelhouderswaarde. Als onderdeel...
Over the past month, the EPRA BELUX index has underperformed (total return) the EPRA Developed Europe index by 3.2%, the STOXX50 by 5.4%, and the BEL20 by 3.6%. This underperformance relative to the EPRA Developed Europe Index can be attributed to the stronger performance of UK real estate compared to eurodenominated stocks, as UK equities led the recovery following a selloff in August. Additionally, the BELUX region had already posted strong year-to-date performance, which limited further upsid...
DEME awarded substantial contract for Formosa 4 offshore wind farm in Taiwan DEME, through its Taiwanese joint venture CDWE, has secured a substantial contract for the Formosa 4 offshore wind farm in Taiwan, covering the transport and installation of 35 foundations and the offshore substation, as well as the scour protection works. Attachment
DEME haalt substantieel contract binnen voor Formosa 4 offshore windpark in Taiwan DEME heeft, via zijn Taiwanese joint venture CDWE, een substantieel contract binnengehaald voor het offshore windpark Formosa 4 in Taiwan. Het contract omvat het transport en de installatie van 35 funderingen en het offshore substation, evenals de werkzaamheden voor erosiebescherming. Bijlage
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.